Compare CNH & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNH | RGC |
|---|---|---|
| Founded | 1842 | 2014 |
| Country | United Kingdom | Hong Kong |
| Employees | 34197 | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.5B |
| IPO Year | N/A | 2020 |
| Metric | CNH | RGC |
|---|---|---|
| Price | $10.17 | $26.78 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $13.38 | N/A |
| AVG Volume (30 Days) | ★ 12.5M | 83.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.31 | N/A |
| P/E Ratio | $31.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.00 | $9.39 |
| 52 Week High | $13.87 | $950.00 |
| Indicator | CNH | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 27.43 | 52.57 |
| Support Level | $9.87 | $24.31 |
| Resistance Level | $11.15 | $27.71 |
| Average True Range (ATR) | 0.36 | 2.61 |
| MACD | -0.21 | 0.02 |
| Stochastic Oscillator | 1.59 | 65.66 |
CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.